2002

December 18, 2002 (PDF)
MaxCyte Launched as Independent Biotechnology Company and Series A Financing Closed

July 10, 2002 (PDF)
MaxCyte and Angiogene Enter into Research Collaboration for Cell-Based Gene Therapy for Congestive Heart Failure

June 5, 2002 (PDF)
MaxCyte's Cell Loading Technology Eliminates Major Gene Transfer Safety Concern

February 27, 2002 (PDF)
R. Michael Blaese, M.D. Joins MaxCyte Scientific Advisory Board

You must have Adobe Acrobat Reader in order to view Press Releases. You can Download the latest version for free.